Ontario Teachers Pension Plan Board Increases Stock Holdings in Solventum Co. (NYSE:SOLV)

Ontario Teachers Pension Plan Board boosted its stake in Solventum Co. (NYSE:SOLV) by 13.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 28,298 shares of the company’s stock after buying an additional 3,310 shares during the quarter. Ontario Teachers Pension Plan Board’s holdings in Solventum were worth $1,869,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Modus Advisors LLC bought a new position in shares of Solventum during the fourth quarter valued at about $25,000. Stonebridge Financial Group LLC purchased a new stake in Solventum in the 4th quarter valued at about $26,000. Crews Bank & Trust bought a new position in shares of Solventum during the 4th quarter worth approximately $32,000. Synergy Asset Management LLC purchased a new position in shares of Solventum in the 4th quarter worth approximately $35,000. Finally, Spire Wealth Management bought a new position in shares of Solventum in the fourth quarter valued at approximately $37,000.

Solventum Stock Performance

Shares of SOLV stock opened at $65.97 on Wednesday. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $85.92. The stock has a market capitalization of $11.41 billion and a P/E ratio of 23.99. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The firm’s 50 day moving average is $73.88 and its 200 day moving average is $71.69.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on SOLV. Piper Sandler boosted their price objective on Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a research report on Friday, February 28th. The Goldman Sachs Group increased their price target on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a research report on Monday, March 3rd. Bank of America lifted their price objective on shares of Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 26th. Morgan Stanley boosted their target price on shares of Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 5th. Finally, Mizuho lifted their price target on shares of Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $79.86.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.